Amlin (LON:AML) Rating Reaffirmed
Amlin (LON:AML) just had their share rating of a ‘”Neutral”‘ issued by research analysts at J.P. Morgan, who now has a GBX 670 target PPS on the 3.32 billion GBP market cap company or a 1.59% upside potential. This key information was revealed to clients and investors in recent note on Monday morning.
From a total of 8 analysts covering Amlin PLC (LON:AML) stock, 0 rate it a ”Buy”, 2 a “Sell”, and 6 a ”Hold”. This means that 0 of the ratings are positive. The highest target price is GBX 675 while the lowest target price is GBX 391. The mean of all analyst targets is GBX 555.50 with a -15.77% below today’s (GBX 659.5) stock price. Amlin PLC was the topic of 16 analyst reports since August 5, 2015 according to the firm StockzIntelligence Inc. JP Morgan maintained shares on November 30 with “Neutral” rating. Credit Suisse maintained shares with “Underperform” rating and GBX 670 target share price in a report from a September 9. UBS maintained AML stock in a recent report from November 16 with “Neutral” rating. Canaccord Genuity maintained the rating on August 24. Canaccord Genuity has a “Hold” rating and a GBX 450 price target on shares. Finally, RBC Capital Markets maintained the stock with “Sector Perform” rating in a report issued on a September 14.
Approximately 61,018 shares of stock traded hands. Amlin plc (LON:AML) has risen 44.53% since May 1, 2015 and is uptrending. It has outperformed by 45.43% the S&P500.
Amlin plc is a United Kingdom-based independent insurer specializing in providing insurance cover to commercial enterprises and reinsurance protection to other insurance companies across the world. The company has a market cap of 3.32 billion GBP. The Company’s Amlin London segment consists of the reinsurance, property and casualty, and marine and aviation business units. It has 14.38 P/E ratio. The Company’s Amlin UK segment is engaged in underwriting commercial insurance in the United Kingdom domestic market, through Amlin Insurance Limited.